Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Ischemic Heart Disease

Free Subscription Articles published in Int J Cardiol Retrieve available abstracts of 318 articles: HTML format

Single Articles

December 2021
1. ZEITZ C
   Relieving angina - interplay between gender, pathophysiology and medication efficacy.
   Int J Cardiol. 2021;345:20-21.
   PubMed    
   
   
   
2. CESARO A, Gragnano F, Calabro P, Moscarella E, et al
   Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry.
   Int J Cardiol. 2021;345:7-13.
   PubMed     Abstract available
   
   
   
3. TAKAHASHI J, Shimokawa H, Yasuda S
   Usefulness of hybrid assessment for coronary functional abnormalities by non-invasive and invasive techniques.
   Int J Cardiol. 2021;345:24-25.
   PubMed    
   
   
   
4. GALLI M, Franchi F
   Guided selection of antiplatelet therapy in acute coronary syndrome: Impact on outcomes and resource utilization.
   Int J Cardiol. 2021;345:36-38.
   PubMed    
   
   
   
5. TSUJITA K
   Realistic detection of natural history of early coronary atherosclerosis: Best part of computed tomography-derived fractional flow reserve?
   Int J Cardiol. 2021;344:34-35.
   PubMed    
   
   
   
6. BERNTORP K, Persson J, Koul SM, Patel MR, et al
   Instantaneous wave-free ratio compared with fractional flow reserve in PCI: A cost-minimization analysis.
   Int J Cardiol. 2021;344:54-59.
   PubMed     Abstract available
   
   
   
7. RIJLAARSDAM-HERMSEN D, van Domburg RT, Deckers JW, Kuijpers D, et al
   Comparison of guidelines for diagnosing suspected stable angina and the additional value of the calcium score.
   Int J Cardiol. 2021;344:1-7.
   PubMed     Abstract available
   
   
   November 2021
8. MARCOS-GARCES V, Perez N, Gavara J, Lopez-Lereu MP, et al
   Risk score for early risk prediction by cardiac magnetic resonance after acute myocardial infarction.
   Int J Cardiol. 2021 Nov 23. pii: S0167-5273(21)01866.
   PubMed     Abstract available
   
   
   
9. GORIKI Y, Yoshioka G, Natsuaki M, Shinzato K, et al
   Simple risk-score model for in-hospital major bleeding based on multiple blood variables in patients with acute myocardial infarction.
   Int J Cardiol. 2021 Nov 18. pii: S0167-5273(21)01862.
   PubMed     Abstract available
   
   
   
10. HENG GE
    Is diastolic dysfunction a new windsock in the risk stratification of patients with coronary heart disease?
    Int J Cardiol. 2021 Nov 17. pii: S0167-5273(21)01853.
    PubMed    
    
    
    
11. DESEIVE S, Orban M
    Choosing the right potent P2Y12-receptor inhibitor in East Asians with acute myocardial infarction and percutaneous coronary intervention - Editorial on Ticagrelor versus Prasugrel in patients with acute myocardial infarction.
    Int J Cardiol. 2021 Nov 16. pii: S0167-5273(21)01848.
    PubMed    
    
    
    
12. TANG LH, Harrison A, Skou ST, Doherty P, et al
    To what extent are comorbidity profiles associated with referral and uptake to cardiac rehabilitation.
    Int J Cardiol. 2021;343:85-91.
    PubMed     Abstract available
    
    
    
13. DIXON LK, Di Tommaso E, Dimagli A, Sinha S, et al
    Impact of sex on outcomes after cardiac surgery: A systematic review and meta-analysis.
    Int J Cardiol. 2021;343:27-34.
    PubMed     Abstract available
    
    
    
14. PYXARAS SA, Harmel EK
    Artificial intelligence for the assessment of coronary artery disease- The dawn of a new era?
    Int J Cardiol. 2021;343:3-4.
    PubMed    
    
    
    
15. FENDER AC, Dobrev D
    Nitric oxide as a fragile switch between cardioprotection and cardiac injury.
    Int J Cardiol. 2021;343:102-103.
    PubMed    
    
    
    
16. NAKAJIMA A, Subban V, Russo M, Bryniarski KL, et al
    Coronary plaque and clinical characteristics of South Asian (Indian) patients with acute coronary syndromes: An optical coherence tomography study.
    Int J Cardiol. 2021;343:171-179.
    PubMed     Abstract available
    
    
    
17. TSUGU T, Tanaka K, Belsack D, Devos H, et al
    Impact of vascular morphology and plaque characteristics on computed tomography derived fractional flow reserve in early stage coronary artery disease.
    Int J Cardiol. 2021;343:187-193.
    PubMed     Abstract available
    
    
    
18. JENSCH PJ, Stiermaier T, Reinstadler SJ, Feistritzer HJ, et al
    Prognostic relevance of peri-infarct zone measured by cardiovascular magnetic resonance in patients with ST-segment elevation myocardial infarction.
    Int J Cardiol. 2021 Nov 10. pii: S0167-5273(21)01785.
    PubMed     Abstract available
    
    
    
19. BANG C, Lauridsen KG, Andersen CF, Lofgren B, et al
    Reply to the Letter to the Editor: "Is single troponin measurement truly safe enough to rule out myocardial infarction in early presenters?"
    Int J Cardiol. 2021 Nov 2. pii: S0167-5273(21)01761.
    PubMed    
    
    
    
20. SOFI F, Dinu M, Reboldi G, Stracci F, et al
    Worldwide differences of hospitalization for ST-segment elevation myocardial infarction during COVID-19: A systematic review and meta-analysis.
    Int J Cardiol. 2021 Nov 2. pii: S0167-5273(21)01765.
    PubMed     Abstract available
    
    
    
21. XU JJ, Cui J, Lin Q, Chen XY, et al
    Protection of the enhanced Nrf2 deacetylation and its downstream transcriptional activity by SIRT1 in myocardial ischemia/reperfusion injury.
    Int J Cardiol. 2021;342:82-93.
    PubMed     Abstract available
    
    
    
22. TRAVERSE JH
    The coronary sinus reducer - Where modern technology meets old school physiology!
    Int J Cardiol. 2021;342:31-32.
    PubMed    
    
    
    
23. COOK CM, Howard JP, Ahmad Y, Shun-Shin MJ, et al
    Comparing invasive hemodynamic responses in adenosine hyperemia versus physical exercise stress in chronic coronary syndromes.
    Int J Cardiol. 2021;342:7-14.
    PubMed     Abstract available
    
    
    
24. LI KS, Bai Y, Li J, Li SL, et al
    LncRNA HCP5 in hBMSC-derived exosomes alleviates myocardial ischemia reperfusion injury by sponging miR-497 to activate IGF1/PI3K/AKT pathway.
    Int J Cardiol. 2021;342:72-81.
    PubMed     Abstract available
    
    
    October 2021
25. HAN X, Chen Z, Wang Y, Zhang J, et al
    Prognostic significance of QRS distortion and frontal QRS-T angle in patients with ST-elevation myocardial infarction.
    Int J Cardiol. 2021 Oct 26. pii: S0167-5273(21)01693.
    PubMed     Abstract available
    
    
    
26. BOUISSET F, Deney A, Ferrieres J, Panagides V, et al
    Mechanical complications in ST-elevation myocardial infarction: The impact of pre-hospital delay.
    Int J Cardiol. 2021 Oct 23. pii: S0167-5273(21)01574.
    PubMed     Abstract available
    
    
    
27. ONO M, Kawashima H, Hara H, Mancone M, et al
    Impact of major infections on 10-year mortality after revascularization in patients with complex coronary artery disease.
    Int J Cardiol. 2021;341:9-12.
    PubMed     Abstract available
    
    
    
28. WEBB CM, Collins P
    Medical management of anginal symptoms in women with stable angina pectoris: A systematic review of randomised controlled trials.
    Int J Cardiol. 2021;341:1-8.
    PubMed     Abstract available
    
    
    
29. GIOVANNINI M, Koniari I, Mori F, Barni S, et al
    Kounis syndrome: Towards a new classification.
    Int J Cardiol. 2021;341:13-14.
    PubMed    
    
    
    
30. CHALIKIAS G, Tziakas DN
    Triggering receptor expressing on myeloid cells (TREM)-1 and acute myocardial infarction: An association vs. causality conundrum.
    Int J Cardiol. 2021 Oct 7. pii: S0167-5273(21)01507.
    PubMed    
    
    
    
31. CHIANG CH, Chiang CH, Chiang CH
    Is single troponin measurement truly safe enough to rule out myocardial infarction in early presenters?
    Int J Cardiol. 2021 Oct 7. pii: S0167-5273(21)01388.
    PubMed    
    
    
    
32. PARK S, Kim YG, Ann SH, Park HW, et al
    Ticagrelor versus prasugrel in patients with acute myocardial infarction.
    Int J Cardiol. 2021 Oct 4. pii: S0167-5273(21)01505.
    PubMed     Abstract available
    
    
    
33. ARCHILLETTI F, Zimarino M
    Intravascular ultrasound for in-stent restenosis: A problem well stated is half-solved.
    Int J Cardiol. 2021;340:22-23.
    PubMed    
    
    
    
34. GUO Y, Li Q, Xuan YT, Wu WJ, et al
    Exercise-induced late preconditioning in mice is triggered by eNOS-dependent generation of nitric oxide and activation of PKCepsilon and is mediated by increased iNOS activity.
    Int J Cardiol. 2021;340:68-78.
    PubMed     Abstract available
    
    
    
35. YONG ASC, Pargaonkar VS, Wong CCY, Javadzdegan A, et al
    Abnormal shear stress and residence time are associated with proximal coronary atheroma in the presence of myocardial bridging.
    Int J Cardiol. 2021;340:7-13.
    PubMed     Abstract available
    
    
    
36. SHLOFMITZ E, Torguson R, Zhang C, Mintz GS, et al
    Impact of intravascular ultrasound on Outcomes following PErcutaneous coronary interventioN for In-stent Restenosis (iOPEN-ISR study).
    Int J Cardiol. 2021;340:17-21.
    PubMed     Abstract available
    
    
    September 2021
37. LENG WX, Yang YJ
    Reply to a fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era.
    Int J Cardiol. 2021 Sep 25. pii: S0167-5273(21)01484.
    PubMed    
    
    
    
38. COSENTINO N, Resta ML, Somaschini A, Campodonico J, et al
    Acute kidney injury and in-hospital mortality in patients with ST-elevation myocardial infarction of different age groups.
    Int J Cardiol. 2021 Sep 17. pii: S0167-5273(21)01383.
    PubMed     Abstract available
    
    
    
39. AIT-OUFELLA H, Yu M, Kotti S, Georges A, et al
    Plasma and genetic determinants of soluble TREM-1 and major adverse cardiovascular events in a prospective cohort of acute myocardial infarction patients. Results from the FAST-MI 2010 study.
    Int J Cardiol. 2021 Sep 15. pii: S0167-5273(21)01379.
    PubMed     Abstract available
    
    
    
40. TEBALDI M, Marrone A
    The management of patients with acute myocardial infarction: route to tailored therapy.
    Int J Cardiol. 2021 Sep 15. pii: S0167-5273(21)01382.
    PubMed    
    
    
    
41. REINDL M, Lechner I, Reinstadler SJ, Metzler B, et al
    Transient STEMI - No STEMI at all?
    Int J Cardiol. 2021;339:12-13.
    PubMed    
    
    
    
42. ISHIHARA T, Dohi T, Nakamura D, Kikuchi A, et al
    Impact of in-stent tissue characteristics on excimer laser coronary angioplasty prior to drug-coated balloon treatment.
    Int J Cardiol. 2021;339:28-32.
    PubMed     Abstract available
    
    
    
43. LIU H, Bi K, Hu Y
    Targeting vimentin in coronary artery disease.
    Int J Cardiol. 2021;339:144.
    PubMed    
    
    
    
44. JANG WJ, Park IH, Yang JH, Chun WJ, et al
    Association between polyvascular disease and clinical outcomes in patients with cardiogenic shock: Results from the RESCUE registry.
    Int J Cardiol. 2021;339:70-74.
    PubMed     Abstract available
    
    
    
45. ANGELINI P, Uribe C
    Where's the beef in anomalous coronary artery origin from an opposite aortic sinus?
    Int J Cardiol. 2021;339:45-46.
    PubMed    
    
    
    
46. ZORZI A, Brunetti G, Cardaioli F, D'Arcangelo F, et al
    Coronary artery calcium on standard chest computed tomography predicts cardiovascular events after liver transplantation.
    Int J Cardiol. 2021;339:219-224.
    PubMed     Abstract available
    
    
    
47. AL-RUBAISH AM, Al-Muhanna FA, Alshehri AM, Al-Mansori MA, et al
    Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patients.
    Int J Cardiol. 2021 Sep 10. pii: S0167-5273(21)01319.
    PubMed     Abstract available
    
    
    
48. ANDERSEN P, Kragholm K, Torp-Pedersen C, Jensen SE, et al
    The impact of peripheral artery disease on major adverse cardiovascular events following myocardial infarction.
    Int J Cardiol. 2021 Sep 6. pii: S0167-5273(21)01321.
    PubMed     Abstract available
    
    
    
49. MAANIITTY T, Stenstrom I, Saraste A, Knuuti J, et al
    Extensive and balanced reduction of myocardial blood flow in patients with suspected obstructive coronary artery disease: 15O-water PET study.
    Int J Cardiol. 2021;338:1-7.
    PubMed     Abstract available
    
    
    
50. LAHU S, Ndrepepa G, Gewalt S, Schupke S, et al
    Efficacy and safety of ticagrelor versus prasugrel in smokers and nonsmokers with acute coronary syndromes.
    Int J Cardiol. 2021;338:8-13.
    PubMed     Abstract available
    
    
    
51. GUO Z, Zhao M, Jia G, Ma R, et al
    LncRNA PART1 alleviated myocardial ischemia/reperfusion injury via suppressing miR-503-5p/BIRC5 mediated mitochondrial apoptosis.
    Int J Cardiol. 2021;338:176-184.
    PubMed     Abstract available
    
    
    
52. REINHOLD J, Papadopoulou C, Baral R, Vassiliou VS, et al
    Reply to commentary on the article entitled "Iron deficiency for prognosis in acute coronary syndrome - A systematic review and meta-analysis".
    Int J Cardiol. 2021;338:41.
    PubMed    
    
    
    
53. ZHENG X, Li J, Fan Q, Zhao X, et al
    Dexmedetomidine alleviates myocardial ischemia/reperfusion-induced injury and Ca(2+) overload via the microRNA-346-3p/CaMKIId axis.
    Int J Cardiol. 2021;338:185-195.
    PubMed     Abstract available
    
    
    August 2021
54. PICARD F, Bhatt DL, Ducrocq G, Ohman EM, et al
    Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) reg
    Int J Cardiol. 2021 Aug 24. pii: S0167-5273(21)01297.
    PubMed     Abstract available
    
    
    
55. FRANGOGIANNIS NG
    Platelet-derived growth factor (PDGF) therapy in myocardial infarction: Challenges and opportunities.
    Int J Cardiol. 2021 Aug 18. pii: S0167-5273(21)01232.
    PubMed    
    
    
    
56. WERNER GS, Lorenz S, Yaginuma K, Koch M, et al
    A prospective study on the incidence of contrast-associated acute kidney injury after recanalization of chronic total coronary occlusions with contemporary interventional techniques.
    Int J Cardiol. 2021;337:38-43.
    PubMed     Abstract available
    
    
    
57. BHATT DL, Kaski JC, Delaney S, Alasnag M, et al
    Results of an international crowdsourcing survey on the treatment of non-ST segment elevation ACS patients at high-bleeding risk undergoing percutaneous intervention.
    Int J Cardiol. 2021;337:1-8.
    PubMed     Abstract available
    
    
    
58. HEGGIE R, Briggs A, Stanley B, Good R, et al
    Stratified medicine using invasive coronary function testing in angina: A cost-effectiveness analysis of the British Heart Foundation CorMicA trial.
    Int J Cardiol. 2021;337:44-51.
    PubMed     Abstract available
    
    
    
59. ANDERSEN CF, Bang C, Lauridsen KG, Frederiksen CA, et al
    Single troponin measurement to rule-out acute myocardial infarction in early presenters.
    Int J Cardiol. 2021 Aug 12. pii: S0167-5273(21)01215.
    PubMed     Abstract available
    
    
    
60. ZUIN M, Rigatelli G
    Thrombus straddling a patent foramen ovale: Also a myocardial infarction matter?
    Int J Cardiol. 2021 Aug 7. pii: S0167-5273(21)01206.
    PubMed    
    
    
    
61. GOLI S, Sakita FM, Kweka GL, Tarimo TG, et al
    Thirty-day outcomes and predictors of mortality following acute myocardial infarction in northern Tanzania: A prospective observational cohort study.
    Int J Cardiol. 2021 Aug 5. pii: S0167-5273(21)01212.
    PubMed     Abstract available
    
    
    
62. PELLICCIA F, Pepine CJ, Berry C, Camici PG, et al
    The role of a comprehensive two-step diagnostic evaluation to unravel the pathophysiology of MINOCA: A review.
    Int J Cardiol. 2021;336:1-7.
    PubMed     Abstract available
    
    
    
63. KARACSONYI J, Alaswad K, Choi JW, Vemmou E, et al
    Laser for balloon uncrossable and undilatable chronic total occlusion interventions.
    Int J Cardiol. 2021;336:33-37.
    PubMed     Abstract available
    
    
    
64. DEIDDA M, Noto A, Cadeddu Dessalvi C, Andreini D, et al
    Metabolomic correlates of coronary atherosclerosis, cardiovascular risk, both or neither. Results of the 2 x 2 phenotypic CAPIRE study.
    Int J Cardiol. 2021;336:14-21.
    PubMed     Abstract available
    
    
    
65. DING Q
    Comment on the article entitled "Iron deficiency for prognosis in acute coronary syndrome - A systematic review and meta-analysis".
    Int J Cardiol. 2021;336:32.
    PubMed    
    
    
    
66. G TOTH G, Johnson NP, Wijns W, Toth B, et al
    Revascularization decisions in patients with chronic coronary syndromes: Results of the second International Survey on Interventional Strategy (ISIS-2).
    Int J Cardiol. 2021;336:38-44.
    PubMed     Abstract available
    
    
    
67. GIANNINI F, Ponticelli F, Guarracini S, Tzanis G, et al
    Reply to: "The importance of evaluating coronary sinus blood flow during the coronary sinus reducer treatment".
    Int J Cardiol. 2021;336:46.
    PubMed    
    
    
    July 2021
68. JAMAL J, O'Loughlin A, French JK
    A fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era.
    Int J Cardiol. 2021 Jul 31. pii: S0167-5273(21)01210.
    PubMed    
    
    
    
69. MATETIC A, Mohamed M, Miller RJH, Kolman L, et al
    Impact of cancer diagnosis on causes and outcomes of 5.9 million US patients with cardiovascular admissions.
    Int J Cardiol. 2021 Jul 29. pii: S0167-5273(21)01197.
    PubMed     Abstract available
    
    
    
70. AIMO A, Panichella G, Barison A, Maffei S, et al
    Sex-related differences in ventricular remodeling after myocardial infarction.
    Int J Cardiol. 2021 Jul 24. pii: S0167-5273(21)01181.
    PubMed     Abstract available
    
    
    
71. JACOBSEN MR, Engstrom T, Torp-Pedersen C, Gislason G, et al
    Clopidogrel, prasugrel, and ticagrelor for all-comers with ST-segment elevation myocardial infarction.
    Int J Cardiol. 2021 Jul 23. pii: S0167-5273(21)01192.
    PubMed     Abstract available
    
    
    
72. MONTONE RA, La Vecchia G
    Interplay between inflammation and microvascular obstruction in ST-elevation myocardial infarction: The importance of velocity.
    Int J Cardiol. 2021 Jul 23. pii: S0167-5273(21)01186.
    PubMed    
    
    
    
73. MONTALTO C, Kotronias RA, Marin F, Terentes-Printzios D, et al
    Pre-procedural ATI score (age-thrombus burden-index of microcirculatory resistance) predicts long-term clinical outcomes in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Int J Cardiol. 2021 Jul 23. pii: S0167-5273(21)01185.
    PubMed     Abstract available
    
    
    
74. PEPE M, Frati G, Biondi-Zoccai G, Corcione N, et al
    Direct and indirect effects of COVID-19 on acute coronary syndromes: Can we pick the worst?
    Int J Cardiol. 2021;335:19-20.
    PubMed    
    
    
    
75. WANG H, Xia Y, Sun Z
    Dexmedetomidine: A potential therapy for myocardial ischemia/reperfusion injury.
    Int J Cardiol. 2021;335:104.
    PubMed    
    
    
    
76. OZLEK B, Ozlek E, Gokcek A
    Reply to the letter: "Kounis syndrome: Towards a new classification".
    Int J Cardiol. 2021;335:25.
    PubMed    
    
    
    
77. MINANA G, Nunez J, Marcos-Garces V, Gavara J, et al
    Long-term prognostic implications of revascularization in patients with known or suspected chronic coronary syndromes without ischemia in vasodilator stress cardiovascular magnetic resonance.
    Int J Cardiol. 2021;335:15-18.
    PubMed     Abstract available
    
    
    
78. NG MY, Chan KYE, Chan CWS
    Cardiac magnetic resonance stress and rest perfusion with T1 mapping: Is it ready to assess for ischaemic heart disease?
    Int J Cardiol. 2021;335:137-138.
    PubMed    
    
    
    
79. SILVERIO A, Galasso G, De Luca G
    Consolidating the value of fondaparinux for current treatment of non-ST-elevation acute coronary syndromes.
    Int J Cardiol. 2021;335:21-23.
    PubMed    
    
    
    
80. BENJAMINS JW, Yeung MW, Maaniitty T, Saraste A, et al
    Improving patient identification for advanced cardiac imaging through machine learning-integration of clinical and coronary CT angiography data.
    Int J Cardiol. 2021;335:130-136.
    PubMed     Abstract available
    
    
    
81. TARUYA A, Nakajima Y, Tanaka A, Kashiwagi M, et al
    Cancer-related vulnerable lesions in patients with stable coronary artery disease.
    Int J Cardiol. 2021;335:1-6.
    PubMed     Abstract available
    
    
    
82. SAMBOLA A, Soriano-Colome T
    Sex disparity in prognosis and costs of type 2 myocardial infarction.
    Int J Cardiol. 2021 Jul 14. pii: S0167-5273(21)01158.
    PubMed    
    
    
    
83. RASHID FN, Clayton ZE, Ogawa M, Perdomo J, et al
    Platelet derived growth factor-A (Pdgf-a) gene transfer modulates scar composition and improves left ventricular function after myocardial infarction.
    Int J Cardiol. 2021 Jul 12. pii: S0167-5273(21)01166.
    PubMed     Abstract available
    
    
    
84. ONG P, Sechtem U
    Diagnostic work-up of patients with myocardial infarction with unobstructed coronary arteries (MINOCA) - Practical considerations.
    Int J Cardiol. 2021 Jul 12. pii: S0167-5273(21)01159.
    PubMed    
    
    
    
85. SHAH P, Jimenez-Ruiz A, Gibson A, Vargas-Gonzalez JC, et al
    Association between acute myocardial infarction and death in 386 patients with a thrombus straddling a patent foramen ovale.
    Int J Cardiol. 2021 Jul 7. pii: S0167-5273(21)01101.
    PubMed     Abstract available
    
    
    
86. LODI RIZZINI M, Nagumo S, Gallo D, Sonck J, et al
    Mismatch between morphological and functional assessment of the length of coronary artery disease.
    Int J Cardiol. 2021;334:1-9.
    PubMed     Abstract available
    
    
    
87. XIONG B, Wang Y, Liu Y, Wu C, et al
    The circulating LncRNA SNHG15/miR-346 axis may be a potential biomarker of cardiomyocyte apoptosis during myocardial ischemia/reperfusion injury.
    Int J Cardiol. 2021;334:30.
    PubMed    
    
    
    
88. XU Y, Yu L, Shen C, Lu Z, et al
    Prevalence and disease features of myocardial ischemia with non-obstructive coronary arteries: Insights from a dynamic CT myocardial perfusion imaging study.
    Int J Cardiol. 2021;334:142-147.
    PubMed     Abstract available
    
    
    
89. GROENLAND EH, Bots ML, Asselbergs FW, de Borst GJ, et al
    Apparent treatment resistant hypertension and the risk of recurrent cardiovascular events and mortality in patients with established vascular disease.
    Int J Cardiol. 2021;334:135-141.
    PubMed     Abstract available
    
    
    
90. DENG J
    Advanced research on the regulated necrosis mechanism in myocardial ischemia-reperfusion injury.
    Int J Cardiol. 2021;334:97-101.
    PubMed     Abstract available
    
    
    
91. VERDOIA M, Barbieri L, De Luca G
    Antiplatelet therapy in ACS elderly patients: Another piece of this intriguing puzzle.
    Int J Cardiol. 2021;334:28-29.
    PubMed    
    
    
    
92. XIE MY, Hou LJ
    Dexmedetomidine down-regulates lncRNA MALAT1 to attenuate myocardial ischemia reperfusion-induced injury by increasing miR-346.
    Int J Cardiol. 2021;334:104.
    PubMed    
    
    
    
93. SUADES R
    miRNA-346-3p/CaMKIId axis: In'DEX'ing a new pharmacological strategy for cardioprotection.
    Int J Cardiol. 2021;334:102-103.
    PubMed    
    
    
    
94. DOAN TT, Molossi S, Sachdeva S, Wilkinson JC, et al
    Dobutamine stress cardiac MRI is safe and feasible in pediatric patients with anomalous aortic origin of a coronary artery (AAOCA).
    Int J Cardiol. 2021;334:42-48.
    PubMed     Abstract available
    
    
    
95. CLAASSENS DMF, Gimbel ME, Bergmeijer TO, Vos GJA, et al
    Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome: A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patients.
    Int J Cardiol. 2021;334:10-17.
    PubMed     Abstract available
    
    
    
96. KOMAKI S, Ishii M, Ikebe S, Kaichi R, et al
    Association between coronary artery calcium score and stent expansion in percutaneous coronary intervention.
    Int J Cardiol. 2021;334:31-36.
    PubMed     Abstract available
    
    
    
97. FLORIAN A
    Diastolic dysfunction in women with ischemia and non-obstructive coronary arteries (INOCA) - Could non-invasive imaging reveal the missing piece of the puzzle?
    Int J Cardiol. 2021;334:21-23.
    PubMed    
    
    
    
98. DAMMAN P, Elias-Smale SE
    How is angina related to coronary microvascular dysfunction? A tip of the veil lifted.
    Int J Cardiol. 2021;334:26-27.
    PubMed    
    
    
    June 2021
99. LI Y, Si S, Hou L, Yuan T, et al
    Causal effect of sex hormone-binding globulin and testosterone on coronary heart disease: A multivariable and network Mendelian randomization analysis.
    Int J Cardiol. 2021 Jun 25. pii: S0167-5273(21)01035.
    PubMed     Abstract available
    
    
    
100. VERDOIA M, Brancati MF, Solda PL
     Commentary to: "Prognosis of spontaneous myocardial infarction and various definitions of periprocedural myocardial infarction in patients who underwent percutaneous coronary intervention".
     Int J Cardiol. 2021 Jun 19. pii: S0167-5273(21)00983.
     PubMed    
     
     
     
101. HOLZKNECHT M, Tiller C, Reindl M, Lechner I, et al
     C-reactive protein velocity predicts microvascular pathology after acute ST-elevation myocardial infarction.
     Int J Cardiol. 2021 Jun 18. pii: S0167-5273(21)00982.
     PubMed     Abstract available
     
     
     
102. KONST RE, Damman P, Pellegrini D, Hartzema-Meijer MJ, et al
     Vasomotor dysfunction in patients with angina and nonobstructive coronary artery disease is dominated by vasospasm.
     Int J Cardiol. 2021;333:14-20.
     PubMed     Abstract available
     
     
     
103. POLZIN A, Helten C, Dannenberg L, Muller T, et al
     Sphingosine-1-phosphate: A mediator of the ARB-MI paradox?
     Int J Cardiol. 2021;333:40-42.
     PubMed     Abstract available
     
     
     
104. DI SERAFINO L, Mangiacapra F, Pyxaras S, Morisco C, et al
     Relationship between peripheral arterial reactive hyperemia and the index of myocardial resistance in patients undergoing invasive coronary angiography.
     Int J Cardiol. 2021;333:8-13.
     PubMed     Abstract available
     
     
     
105. SUPPOGU N, Wei J, Quesada O, Shufelt C, et al
     Angina relates to coronary flow in women with ischemia and no obstructive coronary artery disease.
     Int J Cardiol. 2021;333:35-39.
     PubMed     Abstract available
     
     
     
106. STEINER J, Kerschl M, Erbay A, Abdelwahed YS, et al
     Impact of renal function on outcomes of patients with cardiac troponin elevation and non-obstructive coronary arteries.
     Int J Cardiol. 2021;333:29-34.
     PubMed     Abstract available
     
     
     
107. BUCKLEY JP, Mylotte D, McEvoy JW
     Platelets and poppies: Do morphine and fentanyl differ?
     Int J Cardiol. 2021;333:43-44.
     PubMed    
     
     
     
108. NISHI T, Yamashita R, Imura S, Tateishi K, et al
     Deep learning-based intravascular ultrasound segmentation for the assessment of coronary artery disease.
     Int J Cardiol. 2021;333:55-59.
     PubMed     Abstract available
     
     
     
109. HOSHINO M, Zhang J, Sugiyama T, Yang S, et al
     Prognostic value of pericoronary inflammation and unsupervised machine-learning-defined phenotypic clustering of CT angiographic findings.
     Int J Cardiol. 2021;333:226-232.
     PubMed     Abstract available
     
     
     
110. ANDREOTTI F, Crea F, Patti G, Shoulders CC, et al
     Family history in first degree relatives of patients with premature cardiovascular disease.
     Int J Cardiol. 2021;333:215-218.
     PubMed     Abstract available
     
     
     
111. YANG C, Yang J, Fan Z, Yang J, et al
     ECs-derived exosomes: A novel therapeutic target for myocardial ischemia-reperfusion injury.
     Int J Cardiol. 2021;333:51.
     PubMed    
     
     
     
112. AIMO A, Pelliccia F, Panichella G, Vergaro G, et al
     Indications of beta-adrenoceptor blockers in Takotsubo syndrome and theoretical reasons to prefer agents with vasodilating activity.
     Int J Cardiol. 2021;333:45-50.
     PubMed     Abstract available
     
     
     
113. SACHDEVA S, Desai R, Singh S, Kumar G, et al
     Work from home culture and acute cardiovascular events: A bidirectional conundrum yet to be resolved!
     Int J Cardiol. 2021;333:250.
     PubMed    
     
     
     
114. LI J, Tong Y, Zhou Y, Han Z, et al
     LncRNA KCNQ1OT1 as a miR-26a-5p sponge regulates ATG12-mediated cardiomyocyte autophagy and aggravates myocardial infarction.
     Int J Cardiol. 2021 Jun 2. pii: S0167-5273(21)00910.
     PubMed     Abstract available
     
     
     
115. D'ASCENZO F, De Filippo O, Borin A, Barbieri L, et al
     Impact of COVID-19 pandemic and infection on in hospital survival for patients presenting with acute coronary syndromes: A multicenter registry.
     Int J Cardiol. 2021;332:227-234.
     PubMed     Abstract available
     
     
     
116. VERWEIJ L, Jorstad HT, Minneboo M, Ter Riet G, et al
     The influence of partners on successful lifestyle modification in patients with coronary artery disease.
     Int J Cardiol. 2021;332:195-201.
     PubMed     Abstract available
     
     
     
117. AKSIT E, Altay S, Altun A
     The importance of evaluating coronary sinus blood flow during the coronary sinus reducer treatment.
     Int J Cardiol. 2021;332:38.
     PubMed    
     
     
     
118. SCIAGRA R, Di Paolantonio M, Rubino F, Arnone A, et al
     The STREAM trial: Great expectations for getting clearness in an opaque disease.
     Int J Cardiol. 2021;332:140-141.
     PubMed    
     
     
     
119. CHAO CJ, Shanbhag A, Chiang CC, Girardo ME, et al
     Baseline thrombocytopenia in acute coronary syndrome: The lower, the worse.
     Int J Cardiol. 2021;332:1-7.
     PubMed     Abstract available
     
     
     
120. XIE Z, Zhu J, Li W, Liu L, et al
     Relationship of epicardial fat volume with coronary plaque characteristics, coronary artery calcification score, coronary stenosis, and CT-FFR for lesion-specific ischemia in patients with known or suspected coronary artery disease.
     Int J Cardiol. 2021;332:8-14.
     PubMed     Abstract available
     
     
     
121. SHYU KG, Wang BW, Lin CM
     Reply to the letter to the Editor "ECs-derived exosomes: A novel therapeutic target for myocardial ischemia-reperfusion injury".
     Int J Cardiol. 2021;332:39.
     PubMed    
     
     
     
122. TIAN B, Li T, Wang M
     MicroRNA-19a might be a new potential therapeutic target in the treatment of coronary artery disease.
     Int J Cardiol. 2021;332:164.
     PubMed    
     
     
     
123. TESCHE C, Ellis L, Brandt V
     Non-invasive plaque morphology-based FFR assessment: A new approach to predict ischemic coronary artery disease?
     Int J Cardiol. 2021;332:223-224.
     PubMed    
     
     
     
124. ALMENDRO-DELIA M, Izquierdo-Bajo A, Madrona-Jimenez L, Blanco-Ponce E, et al
     Fondaparinux versus enoxaparin in the contemporary management of non-ST-elevation acute coronary syndromes. Insights from a multicenter registry.
     Int J Cardiol. 2021;332:29-34.
     PubMed     Abstract available
     
     
     May 2021
125. ARISS RW, Elzanaty AM, Minhas AMK, Nazir S, et al
     Sex-based differences in clinical outcomes and resource utilization of type 2 myocardial infarction.
     Int J Cardiol. 2021 May 28. pii: S0167-5273(21)00900.
     PubMed     Abstract available
     
     
     
126. JANSSENS GN, Lemkes JS, van der Hoeven NW, van Leeuwen MAH, et al
     Transient ST-elevation myocardial infarction versus persistent ST-elevation myocardial infarction. An appraisal of patient characteristics and functional outcome.
     Int J Cardiol. 2021 May 15. pii: S0167-5273(21)00830.
     PubMed     Abstract available
     
     
     
127. OTTOSSON F, Emami Khoonsari P, Gerl MJ, Simons K, et al
     A plasma lipid signature predicts incident coronary artery disease.
     Int J Cardiol. 2021;331:249-254.
     PubMed     Abstract available
     
     
     
128. SAMUEL TJ, Wei J, Sharif B, Tamarappoo BK, et al
     Diastolic dysfunction in women with ischemia and no obstructive coronary artery disease: Mechanistic insight from magnetic resonance imaging.
     Int J Cardiol. 2021;331:1-7.
     PubMed     Abstract available
     
     
     
129. ALMUKDAD S, Elewa H, Arafa S, Al-Badriyeh D, et al
     Short- and long-term cost-effectiveness analysis of CYP2C19 genotype-guided therapy, universal clopidogrel, versus universal ticagrelor in post-percutaneous coronary intervention patients in Qatar.
     Int J Cardiol. 2021;331:27-34.
     PubMed     Abstract available
     
     
     
130. SEITZ A, Ong P
     Coexisting microvascular dysfunction in patients with diffuse epicardial coronary spasm: A novel piece of the coronary vasomotor disorder puzzle.
     Int J Cardiol. 2021;331:12-13.
     PubMed    
     
     
     
131. SCHULZ S, Reichert S, Grollmitz J, Friebe L, et al
     The role of Saccharibacteria (TM7) in the subginival microbiome as a predictor for secondary cardiovascular events.
     Int J Cardiol. 2021;331:255-261.
     PubMed     Abstract available
     
     
     
132. FABRIS E, Bhatt DL
     Variation in treatment strategy for NSTEMI: A complex phenomenon.
     Int J Cardiol. 2021;331:14-16.
     PubMed    
     
     
     
133. VARGA-SZEMES A, Schoepf UJ, Maurovich-Horvat P, Wang R, et al
     Coronary plaque assessment of Vasodilative capacity by CT angiography effectively estimates fractional flow reserve.
     Int J Cardiol. 2021;331:307-315.
     PubMed     Abstract available
     
     
     
134. HAITJEMA S, Hoefer IE
     Towards affordable diagnostics and risk management in cardiology: As simple as counting cells?
     Int J Cardiol. 2021;331:206-207.
     PubMed    
     
     
     
135. ECCLESTON D
     Anti-thrombotic therapy for medically managed patients after non-ST segment elevation acute coronary syndromes: Balancing the scales of ischaemic and bleeding risk.
     Int J Cardiol. 2021;331:10-11.
     PubMed    
     
     
     
136. VERDOIA M, De Luca G
     Comments on "Sex differences in distribution, management and outcomes of combined ischemic bleeding risk following acute coronary syndrome".
     Int J Cardiol. 2021;331:8-9.
     PubMed    
     
     
     
137. XIE H, Mao Y, Wang M
     Tackling PTEN induced putative kinase 1 in angiotensin II-induced myocardial injury.
     Int J Cardiol. 2021;331:211.
     PubMed    
     
     
     
138. REINDL M, Reinstadler SJ
     E-wave propagation index (EPI) - A promising echocardiographic marker to improve left ventricular thrombus detection after STEMI?
     Int J Cardiol. 2021;331:331-332.
     PubMed    
     
     
     
139. BETTINK S, Lochel M, Peters D, Haider W, et al
     Efficacy and safety of a magnesium stearate paclitaxel coated balloon catheter in the porcine coronary model.
     Int J Cardiol. 2021;331:46-56.
     PubMed     Abstract available
     
     
     
140. MARTINSSON A, Nielsen SJ, Bjorklund E, Pivodic A, et al
     Renin-angiotensin system inhibition and outcome after coronary artery bypass grafting: A population-based study from the SWEDEHEART registry.
     Int J Cardiol. 2021;331:40-45.
     PubMed     Abstract available
     
     
     
141. XU A, Wang Y, Xiong B, Liu Y, et al
     LncRNA XIST may exert a profibrotic role via sponging miR-133a through SOCS2-activated autophagy in myocardial infarction.
     Int J Cardiol. 2021 May 6. pii: S0167-5273(21)00822.
     PubMed    
     
     
     
142. ULANDER L, Tolppanen H, Hartman O, Rissanen TT, et al
     Hydroxychloroquine reduces interleukin-6 levels after myocardial infarction: The randomized, double-blind, placebo-controlled OXI pilot trial.
     Int J Cardiol. 2021 May 4. pii: S0167-5273(21)00805.
     PubMed     Abstract available
     
     
     
143. MIRO O, Llorens P, Jimenez S, Pinera P, et al
     Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2.
     Int J Cardiol. 2021;330:268-272.
     PubMed    
     
     
     
144. SANTOS-PARDO I, Lagerqvist B, Ritsinger V, Witt N, et al
     Risk of stent failure in patients with diabetes treated with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors: A nationwide observational study.
     Int J Cardiol. 2021;330:23-29.
     PubMed     Abstract available
     
     
     
145. SENGUTTUVAN NB, Suman F, Paneerselvam T, Malepati B, et al
     Comparison of the effect of Morphine and Fentanyl in patients with acute coronary syndrome receiving Ticagrelor - The COMET (Comparison Morphine, Fentayl and Ticagrelor) randomized controlled trial.
     Int J Cardiol. 2021;330:1-6.
     PubMed     Abstract available
     
     
     
146. ASLANGER EK, Meyers HP, Bracey A, Smith SW, et al
     The STEMI/NonSTEMI Dichotomy needs to be replaced by Occlusion MI vs. Non-Occlusion MI.
     Int J Cardiol. 2021;330:15.
     PubMed    
     
     
     
147. DEMIR OM, Schrieken C, Curio J, Rahman H, et al
     Behavioural determinants impacting the adoption rate of coronary physiology.
     Int J Cardiol. 2021;330:12-14.
     PubMed     Abstract available
     
     
     
148. SCHERRENBERG M, Janssen J, Lauwers A, Schreurs I, et al
     Is there an optimal dose of cardiac rehabilitation in coronary artery disease patients?
     Int J Cardiol. 2021;330:7-11.
     PubMed     Abstract available
     
     
     
149. FUNAYAMA N, Kayanuma K, Sunaga D, Yamamoto T, et al
     Serial assessment of de novo coronary lesions after drug-coated balloon treatment analyzed by intravascular ultrasound: A comparison between acute coronary syndrome and stable angina pectoris.
     Int J Cardiol. 2021;330:35-40.
     PubMed     Abstract available
     
     
     April 2021
150. IGLESIAS JF, Muller O, Losdat S, Roffi M, et al
     Multivessel percutaneous coronary intervention with thin-strut biodegradable versus durable polymer drug-eluting stents in ST-segment-elevation myocardial infarction: A subgroup analysis of the BIOSTEMI randomized trial.
     Int J Cardiol. 2021 Apr 19. pii: S0167-5273(21)00670.
     PubMed     Abstract available
     
     
     
151. VERSACI F, Gaspardone A, Danesi A, Ferranti F, et al
     Interplay between COVID-19, pollution, and weather features on changes in the incidence of acute coronary syndromes in early 2020.
     Int J Cardiol. 2021;329:251-259.
     PubMed     Abstract available
     
     
     
152. HARTFORD M, Herlitz H, Perers E, Karlsson T, et al
     Plasma renin activity has a complex prognostic role in patients with acute coronary syndromes.
     Int J Cardiol. 2021;329:198-204.
     PubMed     Abstract available
     
     
     
153. PARCO C, Brockmeyer M, Kosejian L, Quade J, et al
     Modern NCDR and ACTION risk models outperform the GRACE model for prediction of in-hospital mortality in acute coronary syndrome in a German cohort.
     Int J Cardiol. 2021;329:28-35.
     PubMed     Abstract available
     
     
     
154. DEKKER M, Waissi F, Bank IEM, Isgum I, et al
     The prognostic value of automated coronary calcium derived by a deep learning approach on non-ECG gated CT images from (82)Rb-PET/CT myocardial perfusion imaging.
     Int J Cardiol. 2021;329:9-15.
     PubMed     Abstract available
     
     
     
155. PENG Y
     Reply to renal insufficiency and outcomes in patients with acute coronary syndrome.
     Int J Cardiol. 2021;329:49.
     PubMed    
     
     
     
156. SAMBOLA A, Soriano-Colome T
     A sex paradox in clinical outcomes following complex percutaneous intervention. Treatment bias, biology or both?
     Int J Cardiol. 2021;329:77-78.
     PubMed    
     
     
     
157. MOHAMED MO, Rashid M, Timmis A, Clarke S, et al
     Sex differences in distribution, management and outcomes of combined ischemic-bleeding risk following acute coronary syndrome.
     Int J Cardiol. 2021;329:16-22.
     PubMed     Abstract available
     
     
     
158. LEE J, Park DW
     Revascularization or medical therapy for stable coronary artery disease: To do or not to do, that is the question.
     Int J Cardiol. 2021;329:46-47.
     PubMed    
     
     
     
159. CAI Q, Gao ML, Huang LS, Chen HS, et al
     MALAT1/miRNA-203/Wnt5a: A potential mechanism for regulating coronary artery disease.
     Int J Cardiol. 2021;329:48.
     PubMed    
     
     
     
160. NICOLAS J, Claessen BE, Cao D, Chiarito M, et al
     A sex paradox in clinical outcomes following complex percutaneous coronary intervention.
     Int J Cardiol. 2021;329:67-73.
     PubMed     Abstract available
     
     
     
161. FEDOROWSKI A, Erlinge D
     How much is good enough? Insights from myocardial infarction incidence during COVID-19 pandemic.
     Int J Cardiol. 2021 Apr 12. pii: S0167-5273(21)00656.
     PubMed    
     
     
     
162. HUANG SF, Ye WC
     LncRNA MALAT1 facilitated the progression of myocardial infarction by sponging miR-26b.
     Int J Cardiol. 2021 Apr 10. pii: S0167-5273(21)00652.
     PubMed    
     
     
     
163. HOCHHOLZER W, Valina CM
     Antiplatelet therapy for STEMI: Hit it hard and early?
     Int J Cardiol. 2021;328:61-62.
     PubMed    
     
     
     
164. HUANG S, Zeng Z, Sun Y, Cai Y, et al
     Association study of hsa_circ_0001946, hsa-miR-7-5p and PARP1 in coronary atherosclerotic heart disease.
     Int J Cardiol. 2021;328:1-7.
     PubMed     Abstract available
     
     
     
165. REINHOLD J, Papadopoulou C, Baral R, Vassiliou VS, et al
     Iron deficiency for prognosis in acute coronary syndrome - A systematic review and meta-analysis.
     Int J Cardiol. 2021;328:46-54.
     PubMed     Abstract available
     
     
     
166. YOUSIF N, Niederseer D, Davies A, El Issa M, et al
     Impact of malignancy on clinical outcomes in patients with acute coronary syndromes.
     Int J Cardiol. 2021;328:8-13.
     PubMed     Abstract available
     
     
     
167. AHMAD A, Corban MT, Lerman A
     Contrast fractional flow reserve vs adenosine fractional flow reserve: The impact of discordant results.
     Int J Cardiol. 2021;328:59-60.
     PubMed    
     
     
     
168. ORBAN M, Ulrich S, Dischl D, von Samson-Himmelstjerna P, et al
     Cardiac allograft vasculopathy: Differences of absolute and relative intimal hyperplasia in children versus adults in optical coherence tomography.
     Int J Cardiol. 2021;328:227-234.
     PubMed     Abstract available
     
     
     
169. SUGISAWA J, Matsumoto Y, Takeuchi M, Suda A, et al
     Beneficial effects of exercise training on physical performance in patients with vasospastic angina.
     Int J Cardiol. 2021;328:14-21.
     PubMed     Abstract available
     
     
     
170. JEFFRIES A, Costello B, Corkill W, Varghese S, et al
     Prognostic value of coronary artery calcium scoring and computed tomography coronary angiography in remote Indigenous and non-Indigenous Australians.
     Int J Cardiol. 2021;328:241-246.
     PubMed     Abstract available
     
     
     
171. COHEN ARAZI H, Chirino D, Costabel JP, Pulmari CA, et al
     Leuko-platelet index predicts thrombotic events in patients with acute coronary syndrome.
     Int J Cardiol. 2021;328:29-34.
     PubMed     Abstract available
     
     
     
172. MONTALTO C, Crimi G, Morici N, Piatti L, et al
     Bleeding risk prediction in elderly patients managed invasively for acute coronary syndromes: External validation of the PRECISE-DAPT and PARIS scores.
     Int J Cardiol. 2021;328:22-28.
     PubMed     Abstract available
     
     
     
173. EARLE NJ, Poppe KK, Rolleston A, Devlin G, et al
     Outcomes for working age patients after first-time acute coronary syndrome - ANZACS-QI 35.
     Int J Cardiol. 2021;328:55-58.
     PubMed     Abstract available
     
     
     
174. TAVENIER AH, Hermanides RS, Fabris E, Angiolillo DJ, et al
     Bridging the gap: Current and future insights for improving suboptimal platelet inhibition in STEMI.
     Int J Cardiol. 2021;328:40-45.
     PubMed     Abstract available
     
     
     March 2021
175. COMELLA A, Michail M, Chan J, Cameron JD, et al
     Patients with aortic stenosis exhibit early improved endothelial function following transcatheter aortic valve replacement: The eFAST study.
     Int J Cardiol. 2021 Mar 26. pii: S0167-5273(21)00566.
     PubMed     Abstract available
     
     
     
176. ROGNONI A, D'Ascenzo F, Solli M, Mennuni MG, et al
     Return towards normality in admissions for myocardial infarction after the lockdown removal for COVID-19 outbreak in Italy.
     Int J Cardiol. 2021 Mar 22. pii: S0167-5273(21)00550.
     PubMed     Abstract available
     
     
     
177. PELLICCIA F, Rosano GMC, Mehran R
     Corrigendum to "Gender-related differences after acute myocardial infarction: A major global health challenge" [International Journal of Cardiology Volume 311 (2020), 18-19 / DOI: https://doi.org/10.1016/j.ijcard.2020.04.023].
     Int J Cardiol. 2021 Mar 20. pii: S0167-5273(21)00481.
     PubMed    
     
     
     
178. LIU Y, Wang W, Song J, Zhang K, et al
     Prognosis of spontaneous myocardial infarction and various definitions of periprocedural myocardial infarction in patients who underwent percutaneous coronary intervention.
     Int J Cardiol. 2021 Mar 17. pii: S0167-5273(21)00475.
     PubMed     Abstract available
     
     
     
179. LEDDA RE, Milanese G, Sverzellati N
     Might EAT composition help to predict coronary artery disease severity?
     Int J Cardiol. 2021;327:39.
     PubMed    
     
     
     
180. PAPP S, Barczi G, Karady J, Kolossvary M, et al
     Coronary plaque burden of the left anterior descending artery in patients with or without myocardial bridge: A case-control study based on coronary CT-angiography.
     Int J Cardiol. 2021;327:231-235.
     PubMed     Abstract available
     
     
     
181. PAVASINI R, Cardelli LS, Piredda A, Tonet E, et al
     Diastolic dysfunction, frailty and prognosis in elderly patients with acute coronary syndromes.
     Int J Cardiol. 2021;327:31-35.
     PubMed     Abstract available
     
     
     
182. YING S, Li X
     Renal insufficiency and outcomes in patients with acute coronary syndrome.
     Int J Cardiol. 2021;327:36.
     PubMed    
     
     
     
183. HUANG W, Wu X, Xue Y, Zhou Y, et al
     Reply to the Letter to the Editor: "The role of miRNA in regulating epicardial adipose tissue (EAT) inflammation".
     Int J Cardiol. 2021;327:37.
     PubMed    
     
     
     
184. JINNOUCHI H, Sato Y, Cheng Q, Janifer C, et al
     Thromboresistance and endothelial healing in polymer-coated versus polymer-free drug-eluting stents: Implications for short-term dual anti-platelet therapy.
     Int J Cardiol. 2021;327:52-57.
     PubMed     Abstract available
     
     
     
185. LI L, Guan C, Meng S, Bai Y, et al
     Short- and long-term functional results following drug-coated balloons versus drug- eluting stents in small coronary vessels: The RESTORE quantitative flow ratio study.
     Int J Cardiol. 2021;327:45-51.
     PubMed     Abstract available
     
     
     
186. RIEHLE L, Frohlich GM
     Reply to "Comment on: Changes in treatment for NSTEMI in women and the elderly over the past 16 years in a large real-world population".
     Int J Cardiol. 2021;327:38.
     PubMed    
     
     
     
187. TAMARAPPOO B, Samuel TJ, Elboudwarej O, Thomson LEJ, et al
     Left ventricular circumferential strain and coronary microvascular dysfunction: A report from the Women's Ischemia Syndrome Evaluation Coronary Vascular Dysfunction (WISE-CVD) Project.
     Int J Cardiol. 2021;327:25-30.
     PubMed     Abstract available
     
     
     
188. ZHOU J, Chin CT, Huang X, Guo N, et al
     Long-term antiplatelet therapy in medically managed non-ST-segment elevation acute coronary syndromes: The EPICOR Asia study.
     Int J Cardiol. 2021;327:19-24.
     PubMed     Abstract available
     
     
     
189. LEONE AM, Arioti M, Cialdella P, Vergallo R, et al
     Prognostic impact of FFR/contrast FFR discordance.
     Int J Cardiol. 2021;327:40-44.
     PubMed     Abstract available
     
     
     
190. GRESELE P, Guglielmini G, Del Pinto M, Calabro P, et al
     Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry.
     Int J Cardiol. 2021;327:176-182.
     PubMed     Abstract available
     
     
     
191. SCHIELE F, Quignot N, Khachatryan A, Gusto G, et al
     Clinical impact and room for improvement of intensity and adherence to lipid lowering therapy: Five years of clinical follow-up from 164,565 post-myocardial infarction patients.
     Int J Cardiol. 2021 Mar 8. pii: S0167-5273(21)00464.
     PubMed     Abstract available
     
     
     
192. BURRAGE MK, Shanmuganathan M, Masi A, Hann E, et al
     Cardiovascular magnetic resonance stress and rest T1-mapping using regadenoson for detection of ischemic heart disease compared to healthy controls.
     Int J Cardiol. 2021 Mar 8. pii: S0167-5273(21)00467.
     PubMed     Abstract available
     
     
     
193. SHAO X, Chen Y, Su T, Shao X, et al
     Reply to "miRNA-1: A novel, potential therapeutic target in the treatment of acute myocardial infarction?"
     Int J Cardiol. 2021 Mar 8. pii: S0167-5273(21)00468.
     PubMed    
     
     
     
194. STIENEN S, Ferreira JP, Bar C, Thum T, et al
     Serum microRNAs and antifibrotic response to eplerenone in acute myocardial infarction complicated by systolic dysfunction.
     Int J Cardiol. 2021 Mar 4. pii: S0167-5273(21)00399.
     PubMed     Abstract available
     
     
     
195. LAWLESS M, Harrison AS, Doherty P
     Multiple interventions following an acute coronary syndrome event increase uptake into cardiac rehabilitation.
     Int J Cardiol. 2021;326:1-5.
     PubMed     Abstract available
     
     
     
196. ZHAI Y, Yang J, Zhang J, Yang J, et al
     miRNA-3614 derived from epicardial adipose tissue: A novel target for ischemic heart diseases.
     Int J Cardiol. 2021;326:157.
     PubMed    
     
     
     
197. SHIMA Y, Miura K, Shimada T, Ohya M, et al
     Impact of ischemic risk factors on long-term outcomes in patients with and without high bleeding risk.
     Int J Cardiol. 2021;326:12-18.
     PubMed     Abstract available
     
     
     
198. BRUNO VD, Zakkar M
     Instantaneous wave- free ratio for decision making in cardiac surgery, an important step in the right direction.
     Int J Cardiol. 2021;326:71-72.
     PubMed    
     
     
     
199. SABBAH M, Engstrom T, Nepper-Christensen L, Lonborg J, et al
     Does infarct localization and collateral supply confound the association between antiplatelet treatment and infarct size in STEMI?
     Int J Cardiol. 2021;326:42.
     PubMed    
     
     
     
200. LI D, Xiong G, Zeng H, Zhou Q, et al
     Machine learning-aided risk stratification system for the prediction of coronary artery disease.
     Int J Cardiol. 2021;326:30-34.
     PubMed     Abstract available
     
     
     February 2021
201. WANG JD, Qiu F, Li W
     miRNA-1: A novel, potential therapeutic target in the treatment of acute myocardial infarction?
     Int J Cardiol. 2021 Feb 28. pii: S0167-5273(21)00374.
     PubMed    
     
     
     
202. TZIAKAS D, Chalikias G, Al-Lamee R, Kaski JC, et al
     Non ST-elevation myocardial infarction (NSTEMI) patients with total coronary artery occlusion: More than meets the eye.
     Int J Cardiol. 2021 Feb 26. pii: S0167-5273(21)00367.
     PubMed    
     
     
     
203. LIU H, Xie G, Huang W, Liu J, et al
     Rationale and design of a multicenter, randomized, patients-blinded two-stage clinical trial on effects of endothelial function test in patients with non-obstructive coronary artery disease (ENDOFIND).
     Int J Cardiol. 2021;325:16-22.
     PubMed     Abstract available
     
     
     
204. CASE BC, Yerasi C, Forrestal BJ, Shlofmitz E, et al
     Intravascular ultrasound guidance in the evaluation and treatment of left main coronary artery disease.
     Int J Cardiol. 2021;325:168-175.
     PubMed     Abstract available
     
     
     
205. FRACASSI F, Niccoli G, Cosentino N, Eligini S, et al
     Human monocyte-derived macrophages: Pathogenetic role in plaque rupture associated to systemic inflammation.
     Int J Cardiol. 2021;325:1-8.
     PubMed     Abstract available
     
     
     
206. VENETSANOS D, Omerovic E, Sarno G, Pagonis C, et al
     Long term outcome after treatment of de novo coronary artery lesions using three different drug coated balloons.
     Int J Cardiol. 2021;325:30-36.
     PubMed     Abstract available
     
     
     
207. CHOI KH, Lee SH, Lee JM, Hwang D, et al
     Clinical relevance and prognostic implications of contrast quantitative flow ratio in patients with coronary artery disease.
     Int J Cardiol. 2021;325:23-29.
     PubMed     Abstract available
     
     
     
208. LAUKKANEN JA, Kunutsor SK
     Revascularization versus medical therapy for the treatment of stable coronary artery disease: A meta-analysis of contemporary randomized controlled trials.
     Int J Cardiol. 2021;324:13-21.
     PubMed     Abstract available
     
     
     
209. KATAOKA T, Harada K, Tanaka A, Onishi T, et al
     Relationship between epicardial adipose tissue volume and coronary artery spasm.
     Int J Cardiol. 2021;324:8-12.
     PubMed     Abstract available
     
     
     
210. SURUGA K, Miyoshi T, Kotani K, Ichikawa K, et al
     Higher oxidized high-density lipoprotein to apolipoprotein A-I ratio is associated with high-risk coronary plaque characteristics determined by CT angiography.
     Int J Cardiol. 2021;324:193-198.
     PubMed     Abstract available
     
     
     
211. IANNACCONE M, Albani S, Giannini F, Colangelo S, et al
     Short term outcomes of Impella in cardiogenic shock: A review and meta-analysis of observational studies.
     Int J Cardiol. 2021;324:44-51.
     PubMed     Abstract available
     
     
     
212. WADA T, Shiono Y, Kubo T, Honda K, et al
     Impact of instantaneous wave-free ratio on graft failure after coronary artery bypass graft surgery.
     Int J Cardiol. 2021;324:23-29.
     PubMed     Abstract available
     
     
     
213. HUANG W, Wu X, Xue Y, Zhou Y, et al
     MicroRNA-3614 regulates inflammatory response via targeting TRAF6-mediated MAPKs and NF-kappaB signaling in the epicardial adipose tissue with coronary artery disease.
     Int J Cardiol. 2021;324:152-164.
     PubMed     Abstract available
     
     
     
214. ALMENDRO-DELIA M, Seoane Garcia T, Villar Calle P, Garcia Gonzalez N, et al
     Prevalence and clinical significance of totally occluded infarct-related arteries in patients with non-ST-segment elevation acute coronary syndromes.
     Int J Cardiol. 2021;324:1-7.
     PubMed     Abstract available
     
     
     
215. MADIAS JE
     Electrocardiogram features and course in patients with takotsubo syndrome.
     Int J Cardiol. 2021;324:22.
     PubMed    
     
     
     January 2021
216. NICCOLI G, Morrone D, De Rosa S, Montone RA, et al
     The central role of invasive functional coronary assessment for patients with ischemic heart disease.
     Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00137.
     PubMed    
     
     
     
217. NOURAEI H, Rabkin SW
     A new approach to the clinical subclassification of heart failure with preserved ejection fraction.
     Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00134.
     PubMed     Abstract available
     
     
     
218. DAI M, Zhong S
     A pilot study to construct the ceRNA regulatory network of a specific lncRNA in coronary heart disease.
     Int J Cardiol. 2021 Jan 29. pii: S0167-5273(21)00116.
     PubMed    
     
     
     
219. XIE MY, Hou LJ
     LncRNA GAS5 aggravates myocardial infarction by sponging miR-26b.
     Int J Cardiol. 2021 Jan 27. pii: S0167-5273(21)00103.
     PubMed    
     
     
     
220. DE ROQUETAILLADE C, Chousterman BG, Tomasoni D, Zeitouni M, et al
     Unusual arterial thrombotic events in Covid-19 patients.
     Int J Cardiol. 2021;323:281-284.
     PubMed     Abstract available
     
     
     
221. SCHIAVONE M, Gasperetti A, Mancone M, Curnis A, et al
     Oral anticoagulation and clinical outcomes in COVID-19: An Italian multicenter experience.
     Int J Cardiol. 2021;323:276-280.
     PubMed     Abstract available
     
     
     
222. SONG X
     The role of miRNA in regulating epicardial adipose tissue (EAT) inflammation.
     Int J Cardiol. 2021;323:22.
     PubMed    
     
     
     
223. SARAIVA FA, Cerqueira RJ, Savarese G, Leite-Moreira AF, et al
     The tight tie of MAG versus SAG in CABG.
     Int J Cardiol. 2021;323:26.
     PubMed    
     
     
     
224. SELVANAYAGAM JB, Ananthakrishna R, Shirodaria C, Channon K, et al
     Timing of cardiovascular magnetic resonance in clinical trials evaluating cardioprotective therapies to reduce infarct size.
     Int J Cardiol. 2021;323:272-274.
     PubMed    
     
     
     
225. JOLOBE OMP
     The differential diagnosis of STEMI should also be taken into account.
     Int J Cardiol. 2021;323:19.
     PubMed    
     
     
     
226. GUI D, Huang W
     Coronary artery disease is accompanied by increased epicardial fat volume.
     Int J Cardiol. 2021;323:21.
     PubMed    
     
     
     
227. PENG Y, Du X, Li X, Ji J, et al
     Association of renal insufficiency with treatments and outcomes in patients with acute coronary syndrome in China.
     Int J Cardiol. 2021;323:7-12.
     PubMed     Abstract available
     
     
     
228. TZIAKAS D, Chalikias G, Al-Lamee R, Kaski JC, et al
     Total coronary occlusion in non ST elevation myocardial infarction: Time to change our practice?
     Int J Cardiol. 2021 Jan 4. pii: S0167-5273(20)34330.
     PubMed     Abstract available
     
     
     
229. LOW CJ, Leow AS, Syn NL, Tan BY, et al
     Outcomes of left ventricular thrombosis in post-acute myocardial infarction patients stratified by antithrombotic strategies: A meta-analysis with meta-regression.
     Int J Cardiol. 2021 Jan 4. pii: S0167-5273(20)34335.
     PubMed     Abstract available
     
     
     
230. CAI Q, Gao ML, Huang LS, Pan LH, et al
     lncRNA H19/miRNA-1: Another potential mechanism for treating myocardial ischemia-reperfusion injury.
     Int J Cardiol. 2021;322:57.
     PubMed    
     
     
     
231. LOPEZ-DE-SA E
     Acute coronary occlusion in non-STEMI: If you change the way you look at things, the things you look at change.
     Int J Cardiol. 2021;322:49-50.
     PubMed    
     
     
     
232. WU X, Ma JN, Shen LJ, Hu SY, et al
     Reply to "The differential diagnosis of STEMI should also be taken into account".
     Int J Cardiol. 2021;322:55.
     PubMed    
     
     
     
233. OZGEYIK M, Okay Ozgeyik M, Yildirim OT
     Comment on: Changes in treatment for NSTEMI in women and the elderly over the past 16 years in a large real-world population.
     Int J Cardiol. 2021;322:56.
     PubMed    
     
     
     
234. IBRAHIM IM, Farag EM, Tabl MAE, Abdelaziz M, et al
     Relationship between sclerostin and coronary tortuosity in postmenopausal females with non-obstructive coronary artery disease.
     Int J Cardiol. 2021;322:29-33.
     PubMed     Abstract available
     
     
     
235. KEECH A, Way K, Holgate K, Fildes J, et al
     HIIT for post-COVID patients within cardiac rehabilitation: Response to letter to the editor.
     Int J Cardiol. 2021;322:291-292.
     PubMed    
     
     
     
236. YAMADA H
     Epicardial adipose tissue volume is not a simple marker of coronary artery disease.
     Int J Cardiol. 2021;322:45.
     PubMed    
     
     
     
237. LAKSHMANAN S, Budoff MJ
     Where ISCHEMIA fails, coronary CTA shines.
     Int J Cardiol. 2021;322:40-42.
     PubMed    
     
     
     
238. LUSINI M, Nenna A, Chello M
     Endocannabinoid system: A new player in the percutaneous and surgical treatment of coronary artery disease?
     Int J Cardiol. 2021;322:211-212.
     PubMed    
     
     
     
239. KATAOKA Y, Doi T
     Coronary artery ectasia: Importance of its risk stratification and management.
     Int J Cardiol. 2021;322:43-44.
     PubMed    
     
     
     
240. KATAJA A, Tarvasmaki T, Lassus J, Sionis A, et al
     Kinetics of procalcitonin, C-reactive protein and interleukin-6 in cardiogenic shock - Insights from the CardShock study.
     Int J Cardiol. 2021;322:191-196.
     PubMed     Abstract available
     
     
     
241. WU L, Yu J, Wang Q, Lu Y, et al
     Effects of nalbuphine on the cardioprotective effect of morphine in rats.
     Int J Cardiol. 2021;322:207-210.
     PubMed     Abstract available
     
     
     
242. DAI Y, Huang J, Chen Y, Chang S, et al
     Circulating CD34+VEGFR-2+ endothelial progenitor cells correlate with revascularization-mediated long-term improvement of cardiac function in patients with coronary chronic total occlusions.
     Int J Cardiol. 2021;322:1-8.
     PubMed     Abstract available
     
     
     
243. MANGIACAPRA F, Bressi E, Viscusi MM, Creta A, et al
     Non-INvasive Functional and Anatomic vascular evaluation for the prediction of coronary artery disease: The NINFA study.
     Int J Cardiol. 2021;322:16-22.
     PubMed     Abstract available
     
     
     
244. POLYAKOVA EA, Zaraiskii MI, Mikhaylov EN, Baranova EI, et al
     Association of myocardial and serum miRNA expression patterns with the presence and extent of coronary artery disease: A cross-sectional study.
     Int J Cardiol. 2021;322:9-15.
     PubMed     Abstract available
     
     
     December 2020
245. SONG X, Zheng Y, Xue W, Li L, et al
     Identification of risk genes related to myocardial infarction and the construction of early SVM diagnostic model.
     Int J Cardiol. 2020 Dec 19. pii: S0167-5273(20)34255.
     PubMed     Abstract available
     
     
     
246. EMRICH T, Kros M, Schoepf UJ, Geyer M, et al
     Cardiac magnetic resonance imaging features prognostic information in patients with suspected myocardial infarction with non-obstructed coronary arteries.
     Int J Cardiol. 2020 Dec 10. pii: S0167-5273(20)34257.
     PubMed     Abstract available
     
     
     
247. TILLER C, Reindl M, Holzknecht M, Lechner I, et al
     High sensitivity C-reactive protein is associated with worse infarct healing after revascularized ST-elevation myocardial infarction.
     Int J Cardiol. 2020 Dec 9. pii: S0167-5273(20)34253.
     PubMed     Abstract available
     
     
     
248. LENG WX, Yang JG, Li XD, Jiang WY, et al
     Impact of the shift to a fibrinolysis-first strategy on care and outcomes of patients with ST-segment-elevation myocardial infarction during the COVID-19 pandemic-The experience from the largest cardiovascular-specific centre in China.
     Int J Cardiol. 2020 Dec 8. pii: S0167-5273(20)34245.
     PubMed     Abstract available
     
     
     
249. SUN Y, Lin J, Huang S, Xu X, et al
     Preliminary verification of lncRNA ENST00000609755.1 potential ceRNA regulatory network in coronary heart disease.
     Int J Cardiol. 2020 Dec 3. pii: S0167-5273(20)34233.
     PubMed     Abstract available
     
     
     
250. PARK YJ, Lee JH, Kim HJ, Park BE, et al
     Variation in treatment strategy for non-ST segment elevation myocardial infarction: A multilevel methodological approach.
     Int J Cardiol. 2020 Dec 2. pii: S0167-5273(20)34228.
     PubMed     Abstract available
     
     
     
251. LI Y, Liu D, Wu H
     HIIT: A potential rehabilitation treatment in COVID-19 pneumonia with heart disease.
     Int J Cardiol. 2020;320:183.
     PubMed    
     
     
     
252. KISHI T
     Clinical implication of left ventricular preload and afterload reduction during venoarterial extracorporeal membrane oxygenation.
     Int J Cardiol. 2020;320:124-125.
     PubMed    
     
     
     November 2020
253. KOBO O, Contractor T, Mohamed MO, Parwani P, et al
     Impact of pre-existent vascular and poly-vascular disease on acute myocardial infarction management and outcomes: An analysis of 2 million patients from the National Inpatient Sample.
     Int J Cardiol. 2020 Nov 30. pii: S0167-5273(20)34220.
     PubMed     Abstract available
     
     
     
254. CILIBERTI G, Verdoia M, Merlo M, Zilio F, et al
     Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): Insights from a multicentre national registry.
     Int J Cardiol. 2020 Nov 23. pii: S0167-5273(20)34163.
     PubMed     Abstract available
     
     
     
255. BARBATO E, Knuuti J, Wijns W
     From fallacies to reality: Focus on fractional flow reserve.
     Int J Cardiol. 2020;319:61.
     PubMed    
     
     
     
256. CHOUDHARY R, Gautam DK
     Optimal antiplatelet strategy in Asian patients presenting with acute coronary syndrome.
     Int J Cardiol. 2020;319:37.
     PubMed    
     
     
     
257. WANG H, Zhang Y, Shen Z, Fang L, et al
     Response to letter to the editor on "Percutaneous coronary intervention underperforms in Takayasu Arteritis".
     Int J Cardiol. 2020;319:38-39.
     PubMed    
     
     
     
258. DUUS LS, Pedersen S, Ravnkilde K, Galatius S, et al
     Association between the E-wave propagation index and left ventricular thrombus formation after ST-elevation myocardial infarction.
     Int J Cardiol. 2020 Nov 2. pii: S0167-5273(20)34071.
     PubMed     Abstract available
     
     
     
259. AGSTAM S, Gupta A
     Percutaneous coronary intervention underperforms in Takayasu Arteritis.
     Int J Cardiol. 2020;318:144.
     PubMed    
     
     
     
260. VINCI MC, Bassetti B, Pompilio G
     Endothelial progenitors: When confusion may give rise to new understanding.
     Int J Cardiol. 2020;318:121-122.
     PubMed    
     
     
     
261. LANDI A, De Servi S
     Time-dependent impact of Ticagrelor and Prasugrel on infarct size: Looking beyond antiplatelet effect.
     Int J Cardiol. 2020;318:26.
     PubMed    
     
     
     
262. DUFLOS C, Roubille C, Roubille F
     By half decrease of cardiovascular mortality in a Western country between 2000 and 2015: A contrasted picture advocating for a better management of comorbidities.
     Int J Cardiol. 2020;318:145-146.
     PubMed    
     
     
     October 2020
263. RAVAL AN, Johnston PV, Duckers HJ, Cook TD, et al
     Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort.
     Int J Cardiol. 2020 Oct 19. pii: S0167-5273(20)33996.
     PubMed     Abstract available
     
     
     
264. GOULD KL
     FFR at high heart rate - Unexpected physiologic insights.
     Int J Cardiol. 2020;317:44-46.
     PubMed    
     
     
     
265. ROKOS IC
     Artificial intelligence for STEMI detection: The "Shanghai Algorithm" provides a step forward.
     Int J Cardiol. 2020;317:231-232.
     PubMed    
     
     
     
266. LEONE AM
     Post PCI FFR: More questions than answers?
     Int J Cardiol. 2020;317:42-43.
     PubMed    
     
     
     
267. VALLABHAJOSYULA S
     Reply to 'The potentially fatal consequences of fibrinolysis in misdiagnosed patients with aortic dissection'.
     Int J Cardiol. 2020 Oct 5. pii: S0167-5273(20)33910.
     PubMed    
     
     
     
268. MYHRE PL, Lyngbakken MN, Rosjo H, Omland T, et al
     Removing stable and adding precision to chronic coronary artery disease.
     Int J Cardiol. 2020;316:54-56.
     PubMed    
     
     
     September 2020
269. GIRALT T, Ribas N, Freixa X, Sabate M, et al
     Impact of pre-angioplasty antithrombotic therapy administration on coronary reperfusion in ST-segment elevation myocardial infarction: Does time matter?
     Int J Cardiol. 2020 Sep 26. pii: S0167-5273(20)33839.
     PubMed     Abstract available
     
     
     
270. ZHU F, Liu Y, Tang K
     MicroRNA-26b might be a novel therapeutic target in the treatment of myocardial infarction.
     Int J Cardiol. 2020 Sep 16. pii: S0167-5273(20)33741.
     PubMed    
     
     
     
271. JOLOBE OMP
     The potentially fatal consequences of fibrinolysis in misdiagnosed subjects with aortic dissection.
     Int J Cardiol. 2020 Sep 10. pii: S0167-5273(20)33798.
     PubMed    
     
     
     August 2020
272. PASTORI D, Carnevale R, Stanzione R, Nocella C, et al
     T2238C atrial natriuretic peptide gene variant and cardiovascular events in patients with atrial fibrillation: A substudy from the ATHERO-AF cohort.
     Int J Cardiol. 2020 Aug 27. pii: S0167-5273(20)33704.
     PubMed     Abstract available
     
     
     
273. ZHAO J, Pan J
     Circulating Serpina3 might be a new potential biomarker to predict the clinical outcomes in AMI.
     Int J Cardiol. 2020;312:108.
     PubMed    
     
     
     
274. LUCINI D, Pagani M
     Heart rate variability, autonomic regulation and myocardial ischemia.
     Int J Cardiol. 2020;312:22-23.
     PubMed    
     
     
     July 2020
275. GAIBAZZI N
     Are we "bridging" the gap?
     Int J Cardiol. 2020;311:114-115.
     PubMed    
     
     
     
276. LAUKKANEN JA, Kunutsor SK
     A potential case for the routine assessment of cardiorespiratory fitness level in clinical practice.
     Int J Cardiol. 2020;310:145-146.
     PubMed    
     
     
     
277. YANG C, Fan Z, Yang J
     Urgent to correctly understand the role of aspirin in cardiovascular disease.
     Int J Cardiol. 2020;310:33.
     PubMed    
     
     
     June 2020
278. SCARSINI R, Lunardi M, Venturi G, Pighi M, et al
     Long-term variations of FFR and iFR after transcatheter aortic valve implantation.
     Int J Cardiol. 2020 Jun 3. pii: S0167-5273(20)31098.
     PubMed     Abstract available
     
     
     May 2020
279. LIMBRUNO U, Goette A, De Caterina R
     Commentary: Temporarily omitting oral anticoagulants early after stenting for acute coronary syndromes patients with atrial fibrillation.
     Int J Cardiol. 2020 May 7. pii: S0167-5273(20)32667.
     PubMed     Abstract available
     
     
     
280. SVENNINGSSON MM, Svingen GFT, Lysne V, Ueland PM, et al
     Transsulfuration metabolites and the association with incident atrial fibrillation - An observational cohort study among Norwegian patients with stable angina pectoris.
     Int J Cardiol. 2020 May 7. pii: S0167-5273(20)30694.
     PubMed     Abstract available
     
     
     April 2020
281. PUGLIESE NR, Masi S
     Circulating interleukins, coronary artery disease, ischemic stroke and atrial fibrillation: Connecting the dots between inflammation and cardiovascular disease.
     Int J Cardiol. 2020 Apr 21. pii: S0167-5273(20)31424.
     PubMed    
     
     
     March 2020
282. YUAN S, Lin A, He QQ, Burgess S, et al
     Circulating interleukins in relation to coronary artery disease, atrial fibrillation and ischemic stroke and its subtypes: A two-sample Mendelian randomization study.
     Int J Cardiol. 2020 Mar 21. pii: S0167-5273(20)30701.
     PubMed     Abstract available
     
     
     
283. ALHAKAK AS, Mogelvang R, Schnohr P, Modin D, et al
     The cardiac isovolumetric contraction time is an independent predictor of incident heart failure in the general population.
     Int J Cardiol. 2020 Mar 19. pii: S0167-5273(19)35169.
     PubMed     Abstract available
     
     
     
284. GOEL S, Pasam RT, Chava S, Gotesman J, et al
     Orbital atherectomy versus rotational atherectomy: A systematic review and meta-analysis.
     Int J Cardiol. 2020;303:16-21.
     PubMed     Abstract available
     
     
     
285. GENCER B, Carballo D, Nanchen D, Koskinas KC, et al
     Intensified lipid lowering using ezetimibe after publication of the IMPROVE-IT trial: A contemporary analysis from the SPUM-ACS cohort.
     Int J Cardiol. 2020;303:8-13.
     PubMed     Abstract available
     
     
     
286. NUNEZ J, Palau P, Sastre C, D'Ascoli G, et al
     Sex-differential effect of frailty on long-term mortality in elderly patients after an acute coronary syndrome.
     Int J Cardiol. 2020;302:30-33.
     PubMed     Abstract available
     
     
     
287. SOARES A, Brown DL
     The fallacies of fractional flow reserve.
     Int J Cardiol. 2020;302:34-35.
     PubMed    
     
     
     
288. KITE TA, Gaunt H, Banning AS, Roberts E, et al
     Clinical outcomes of patients discharged from the Rapid Access Chest Pain Clinic with non-anginal chest pain: A retrospective cohort study.
     Int J Cardiol. 2020;302:1-4.
     PubMed     Abstract available
     
     
     February 2020
289. MICALI LR, Parise G, Moula AI, Alayed Y, et al
     Are recurrence of ischemic mitral regurgitation and left ventricular reverse remodeling after restrictive annuloplasty ring dependent?
     Int J Cardiol. 2020 Feb 27. pii: S0167-5273(19)34381.
     PubMed     Abstract available
     
     
     
290. RASHID M, Curzen N, Kinnaird T, Lawson CA, et al
     Baseline risk, timing of invasive strategy and guideline compliance in NSTEMI: Nationwide analysis from MINAP.
     Int J Cardiol. 2020;301:7-13.
     PubMed     Abstract available
     
     
     
291. DENG XQ, Xu XJ, Wu SH, Li H, et al
     Association between resting painless ST-segment depression with sudden cardiac death in middle-aged population: A prospective cohort study.
     Int J Cardiol. 2020;301:1-6.
     PubMed     Abstract available
     
     
     
292. LADDU DR, Ozemek C, Hauer TL, Rouleau CR, et al
     Cardiometabolic responses to cardiac rehabilitation in people with and without diabetes.
     Int J Cardiol. 2020;301:156-162.
     PubMed     Abstract available
     
     
     
293. BIANCO M, D'ascenzo F, Raposeiras Roubin S, Kinnaird T, et al
     Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor.
     Int J Cardiol. 2020;301:200-206.
     PubMed     Abstract available
     
     
     
294. CARRIE D, Berland J, Verheye S, Hauptmann KE, et al
     Five-year clinical outcome of multicenter randomized trial comparing amphilimus - with paclitaxel-eluting stents in de novo native coronary artery lesions.
     Int J Cardiol. 2020;301:50-55.
     PubMed     Abstract available
     
     
     
295. ELY PIZZATO P, Samdani AJ, Vergara-Martel A, Palma Dallan LA, et al
     Feasibility of coronary angiogram-derived vessel fractional flow reserve in the setting of standard of care percutaneous coronary intervention and its correlation with invasive FFR.
     Int J Cardiol. 2020;301:45-49.
     PubMed     Abstract available
     
     
     
296. RAMASAMY A, Chen Y, Zanchin T, Jones DA, et al
     Optical coherence tomography enables more accurate detection of functionally significant intermediate non-left main coronary artery stenoses than intravascular ultrasound: A meta-analysis of 6919 patients and 7537 lesions.
     Int J Cardiol. 2020;301:226-234.
     PubMed     Abstract available
     
     
     
297. PONTONE G, Guaricci AI, Palmer SC, Andreini D, et al
     Diagnostic performance of non-invasive imaging for stable coronary artery disease: A meta-analysis.
     Int J Cardiol. 2020;300:276-281.
     PubMed     Abstract available
     
     
     
298. QU Y, Yang J, Zhang F, Li C, et al
     Relationship between body mass index and outcomes of coronary artery disease in Asian population: Insight from the FOCUS registry.
     Int J Cardiol. 2020;300:262-267.
     PubMed     Abstract available
     
     
     
299. QUINTANA RA, Monlezun DJ, Davogustto G, Saenz HR, et al
     Outcomes following percutaneous coronary intervention in patients with cancer.
     Int J Cardiol. 2020;300:106-112.
     PubMed     Abstract available
     
     
     
300. WITBERG G, Zusman O, Bental T, Plakht I, et al
     Validation of the DAPT score in real-world patients undergoing coronary stent implantation.
     Int J Cardiol. 2020;300:99-105.
     PubMed     Abstract available
     
     
     
301. CONTE E, Sonck J, Mushtaq S, Collet C, et al
     FFRCT and CT perfusion: A review on the evaluation of functional impact of coronary artery stenosis by cardiac CT.
     Int J Cardiol. 2020;300:289-296.
     PubMed     Abstract available
     
     
     
302. HIDEO-KAJITA A, Garcia-Garcia HM, Kolm P, Azizi V, et al
     Comparison of clinical outcomes between Magmaris and Orsiro drug eluting stent at 12months: Pooled patient level analysis from BIOSOLVE II-III and BIOFLOW II trials.
     Int J Cardiol. 2020;300:60-65.
     PubMed     Abstract available
     
     
     
303. KERKMEIJER LSM, Tijssen RYG, Hofma SH, Pinxterhuis TH, et al
     A paradox in sex-specific clinical outcomes after bioresorbable scaffold implantation: 2-year results from the AIDA trial.
     Int J Cardiol. 2020;300:93-98.
     PubMed     Abstract available
     
     
     January 2020
304. BUTTY A, Gencer B, Koskinas KC, Carballo D, et al
     Control of cardiovascular risk factors and health behaviors in patients post acute coronary syndromes eligible for protein convertase subtilisin/kexin-9 inhibitors.
     Int J Cardiol. 2020;299:289-295.
     PubMed     Abstract available
     
     
     
305. PARIKH RV, Pargaonkar V, Ball RL, Kobayashi Y, et al
     Asymmetric dimethylarginine predicts impaired epicardial coronary vasomotion in patients with angina in the absence of obstructive coronary artery disease.
     Int J Cardiol. 2020;299:7-11.
     PubMed     Abstract available
     
     
     
306. NUNEZ-GIL IJ, Cerrato E, Bollati M, Nombela-Franco L, et al
     Coronary artery aneurysms, insights from the international coronary artery aneurysm registry (CAAR).
     Int J Cardiol. 2020;299:49-55.
     PubMed     Abstract available
     
     
     
307. LEONE AM, Campo G, Gallo F, Pavasini R, et al
     Adenosine-Free Indexes vs. Fractional Flow Reserve for Functional Assessment of Coronary Stenoses: Systematic Review and Meta-Analysis.
     Int J Cardiol. 2020;299:93-99.
     PubMed     Abstract available
     
     
     
308. AL-RASHID F, Totzeck M, Mahabadi AA, Johannsen L, et al
     Safety and efficacy of a novel algorithm to guide decision-making in high-risk interventional coronary procedures.
     Int J Cardiol. 2020;299:87-92.
     PubMed     Abstract available
     
     
     
309. BRANKOVIC M, Kardys I, van den Berg V, Oemrawsingh R, et al
     Evolution of renal function and predictive value of serial renal assessments among patients with acute coronary syndrome: BIOMArCS study.
     Int J Cardiol. 2020;299:12-19.
     PubMed     Abstract available
     
     
     
310. KOO CY, Chua AP, Kristanto W, Koh EH, et al
     Screening and treatment of obstructive sleep apnea in acute coronary syndrome. A randomized clinical trial.
     Int J Cardiol. 2020;299:20-25.
     PubMed     Abstract available
     
     
     
311. XENOGIANNIS I, Karmpaliotis D, Alaswad K, Jaffer FA, et al
     Impact of concomitant treatment of non-chronic total occlusion lesions at the time of chronic total occlusion intervention.
     Int J Cardiol. 2020;299:75-80.
     PubMed     Abstract available
     
     
     
312. BAE JH, Corban MT, Seo YH, Kim T, et al
     Ten-year clinical outcomes of an intermediate coronary lesion; prognosis and predictors of major adverse cardiovascular events.
     Int J Cardiol. 2020;299:26-30.
     PubMed     Abstract available
     
     
     
313. HONG SJ, Park KH, Ahn CM, Kim JS, et al
     Severe acute stent malapposition follow-up: 3-month and 12-month serial quantitative analyses by optical coherence tomography.
     Int J Cardiol. 2020;299:81-86.
     PubMed     Abstract available
     
     
     
314. KINNAIRD T, Kwok CS, Davies R, Calvert PA, et al
     Coronary perforation complicating percutaneous coronary intervention in patients presenting with an acute coronary syndrome: An analysis of 1013 perforation cases from the British Cardiovascular Intervention Society database.
     Int J Cardiol. 2020;299:37-42.
     PubMed     Abstract available
     
     
     
315. KEECH A, Holgate K, Fildes J, Indraratna P, et al
     High-intensity interval training for patients with coronary artery disease: Finding the optimal balance.
     Int J Cardiol. 2020;298:8-14.
     PubMed     Abstract available
     
     
     
316. SILVA AC, de Antonio VZ, Sroubek J, Gervino E, et al
     Exercise and pharmacologic stress-induced interlead T-wave heterogeneity analysis to detect clinically significant coronary artery stenosis.
     Int J Cardiol. 2020;298:32-38.
     PubMed     Abstract available
     
     
     December 2019
317. RUAN Y, Robinson NB, Naik A, Silva M, et al
     Effect of atrial pacing on post-operative atrial fibrillation following coronary artery bypass grafting: Pairwise and network meta-analyses.
     Int J Cardiol. 2019 Dec 6. pii: S0167-5273(19)35145.
     PubMed     Abstract available
     
     
     November 2019
318. MARCUS G, Shimony S, Stein GY, Matezky S, et al
     Incidence, predictors and prognostic implications of dyspnea at admission among acute coronary syndrome patients without heart failure.
     Int J Cardiol. 2019 Nov 9. pii: S0167-5273(19)32270.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: